Research Analysts’ Weekly Ratings Updates for Healthequity (HQY)

Healthequity (NASDAQ: HQY) recently received a number of ratings updates from brokerages and research firms:

  • 4/5/2018 – Healthequity had its price target raised by analysts at KeyCorp from $66.00 to $72.00. They now have an “overweight” rating on the stock.
  • 4/4/2018 – Healthequity was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
  • 4/3/2018 – Healthequity was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $68.00 price target on the stock. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
  • 4/2/2018 – Healthequity was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 3/28/2018 – Healthequity was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
  • 3/27/2018 – Healthequity was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $71.00 price target on the stock. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
  • 3/23/2018 – Healthequity had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock. They wrote, “On March 22, 2018, we hosted a day of investor meetings with the senior management team of HQY.””
  • 3/20/2018 – Healthequity had its price target raised by analysts at KeyCorp from $62.00 to $66.00. They now have an “overweight” rating on the stock.
  • 3/20/2018 – Healthequity had its price target raised by analysts at Barrington Research to $65.00. They now have an “outperform” rating on the stock.
  • 3/20/2018 – Healthequity had its price target raised by analysts at Oppenheimer Holdings from $58.00 to $68.00. They now have an “outperform” rating on the stock.
  • 3/20/2018 – Healthequity had its price target raised by analysts at Citigroup from $58.00 to $68.00. They now have an “outperform” rating on the stock.
  • 3/20/2018 – Healthequity had its price target raised by analysts at Robert W. Baird from $49.00 to $61.00. They now have a “neutral” rating on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 3/20/2018 – Healthequity had its price target raised by analysts at Chardan Capital from $62.00 to $77.00. They now have a “buy” rating on the stock.
  • 3/20/2018 – Healthequity had its price target raised by analysts at SunTrust Banks to $70.00. They now have a “buy” rating on the stock.
  • 3/2/2018 – Healthequity was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 2/27/2018 – Healthequity was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. They now have a $62.00 price target on the stock. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
  • 2/22/2018 – Healthequity had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock. They wrote, “On February 22, 2018, Devenir Research released its annual HSA market report. According to the report, HSA account growth slowed in 2017.””
  • 2/16/2018 – Healthequity was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.

Shares of HQY traded up $1.18 on Tuesday, reaching $65.38. The stock had a trading volume of 233,739 shares, compared to its average volume of 660,903. The stock has a market cap of $3,869.24, a PE ratio of 121.07, a PEG ratio of 2.54 and a beta of 1.39. Healthequity Inc has a 12-month low of $40.21 and a 12-month high of $68.75.

How to Become a New Pot Stock Millionaire

Healthequity (NASDAQ:HQY) last released its earnings results on Monday, March 19th. The company reported $0.06 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.06. Healthequity had a return on equity of 13.47% and a net margin of 20.64%. The company had revenue of $60.44 million during the quarter, compared to analysts’ expectations of $58.46 million. sell-side analysts predict that Healthequity Inc will post 0.77 EPS for the current fiscal year.

In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $48.00, for a total value of $456,000.00. Following the completion of the sale, the vice president now owns 99,500 shares of the company’s stock, valued at approximately $4,776,000. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Ashley Dreier sold 12,000 shares of Healthequity stock in a transaction on Monday, January 29th. The stock was sold at an average price of $52.00, for a total value of $624,000.00. Following the completion of the sale, the vice president now directly owns 17,652 shares of the company’s stock, valued at approximately $917,904. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 750,831 shares of company stock valued at $40,420,618. 19.00% of the stock is owned by corporate insiders.

Several institutional investors have recently bought and sold shares of HQY. Carillon Tower Advisers Inc. bought a new stake in shares of Healthequity in the 4th quarter worth $34,100,000. Victory Capital Management Inc. increased its holdings in shares of Healthequity by 116.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after purchasing an additional 555,027 shares in the last quarter. Eagle Asset Management Inc. increased its holdings in shares of Healthequity by 58.6% in the 4th quarter. Eagle Asset Management Inc. now owns 1,136,645 shares of the company’s stock worth $53,206,000 after purchasing an additional 419,914 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Healthequity by 3.8% in the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after purchasing an additional 244,819 shares in the last quarter. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Healthequity by 33.4% in the 4th quarter. TimesSquare Capital Management LLC now owns 644,535 shares of the company’s stock worth $30,074,000 after purchasing an additional 161,335 shares in the last quarter. 99.17% of the stock is owned by institutional investors and hedge funds.

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply